UNITED THERAPEUTICS Corp — Director's Dealing 2021

Jul 9, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2021-07-08

Reporting Person: Mesa Nilda (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-07-08	Stock Options	$183.98	A	3230	Acquired	2031-07-08	Common Stock (3230)	Direct
2021-07-08	Restricted Stock Units	$0	A	1080	Acquired		Common Stock (1080)	Direct

Footnotes

F1: Annual non-employee director grant of stock options, which are awarded and priced each year on the date of the first board meeting following the issuer's Annual Meeting of Shareholders.

F2: Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.

F3: Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.

F4: Annual non-employee director grant of restricted stock units, which are awarded each year on the date of the first board meeting following the issuer's Annual Meeting of Shareholders.